329 related articles for article (PubMed ID: 30725444)
1. Linear epitope binding antibodies against GII.3 Norovirus exhibit no histo-blood group antigens (HBGAs) blocking effects.
Ma S; Zhang F; Zheng L; Liu J; Ma J; Chen X; Yang Z; Wang W; Li L; Wang M; Huo Y
Virus Genes; 2019 Jun; 55(3):280-289. PubMed ID: 30725444
[TBL] [Abstract][Full Text] [Related]
2. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
[TBL] [Abstract][Full Text] [Related]
3. Chimeric GII.3/GII.6 norovirus capsid (VP1) proteins: characterization by electron microscopy, trypsin sensitivity and binding to histo-blood group antigens.
Ma S; Zheng L; Liu J; Wang W; Ma J; Cheng X; Ge L; Wang M; Huo Y; Shen S
Arch Virol; 2018 Dec; 163(12):3265-3273. PubMed ID: 30143876
[TBL] [Abstract][Full Text] [Related]
4. Biological and immunological characterization of norovirus major capsid proteins from three different genotypes.
Huo Y; Wan X; Ling T; Shen S
Microb Pathog; 2016 Jan; 90():78-83. PubMed ID: 26616166
[TBL] [Abstract][Full Text] [Related]
5. Characterization of virus-like particles derived from a GII.3 norovirus strain distantly related with current dominating strains.
Huo Y; Chen X; Zheng L; Huo J; Zhang S; Wang M; Wang Y
Virus Genes; 2016 Oct; 52(5):613-9. PubMed ID: 27234312
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China.
Huo Y; Zheng L; Chen X; Ge L; Wang Y
Microb Pathog; 2017 Apr; 105():131-137. PubMed ID: 28219831
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic cleavage promotes disassembly of GII.3 norovirus virus like particles and its binding to salivary histo-blood group antigens.
Huo Y; Wang W; Zheng L; Chen X; Shen S; Wang M
Virus Res; 2017 Aug; 240():18-24. PubMed ID: 28754559
[TBL] [Abstract][Full Text] [Related]
8. Genomic and biological characterization of a pandemic norovirus variant GII.4 Sydney 2012.
Ge L; Chen X; Liu J; Zheng L; Chen C; Luo S; Guo P; Kong J; Song Y; Huo Y
Virus Genes; 2020 Apr; 56(2):174-181. PubMed ID: 31912284
[TBL] [Abstract][Full Text] [Related]
9. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.
Debbink K; Donaldson EF; Lindesmith LC; Baric RS
J Virol; 2012 Jan; 86(2):1214-26. PubMed ID: 22090110
[TBL] [Abstract][Full Text] [Related]
10. Identification of Human Norovirus GII.3 Blockade Antibody Epitopes.
Yi Y; Wang S; Wang X; Xiong P; Liu Q; Zhang C; Yin F; Huang Z
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696487
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive characterization of a major capsid protein derived from a documented GII.6 norovirus strain.
Zheng L; Wang W; Liu J; Huo Y; Qin C; Wang M; Shen S
Arch Virol; 2017 Dec; 162(12):3863-3868. PubMed ID: 28866835
[TBL] [Abstract][Full Text] [Related]
12. Phylogenetic and biological characterizations of a GI.3 norovirus.
Zheng L; Zhang H; Ma J; Liu J; Ma S; Wang M; Huo Y
Infect Genet Evol; 2020 Nov; 85():104554. PubMed ID: 32927119
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.
Mahar JE; Donker NC; Bok K; Talbo GH; Green KY; Kirkwood CD
J Virol; 2014 Feb; 88(4):1942-52. PubMed ID: 24284328
[TBL] [Abstract][Full Text] [Related]
14. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
Malm M; Tamminen K; Vesikari T; Blazevic V
Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
[TBL] [Abstract][Full Text] [Related]
15. Identification of a blockade epitope of human norovirus GII.17.
Yi Y; Wang X; Wang S; Xiong P; Liu Q; Zhang C; Yin F; Huang Z
Emerg Microbes Infect; 2021 Dec; 10(1):954-963. PubMed ID: 33929932
[TBL] [Abstract][Full Text] [Related]
16. The surface-exposed loop region of norovirus GII.3 VP1 plays an essential role in binding histo-blood group antigens.
Zhang G; Wang J; Liu J; Zheng L; Wang W; Huo Y; Sun X
Arch Virol; 2019 Jun; 164(6):1629-1638. PubMed ID: 30968211
[TBL] [Abstract][Full Text] [Related]
17. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
Malm M; Tamminen K; Vesikari T; Blazevic V
Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
[TBL] [Abstract][Full Text] [Related]
18. Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.
Sharma S; Carlsson B; Czakó R; Vene S; Haglund M; Ludvigsson J; Larson G; Hammarström L; Sosnovtsev SV; Atmar RL; Green KY; Estes MK; Svensson L
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468886
[TBL] [Abstract][Full Text] [Related]
19. Expression of chimeric proteins based on a backbone of the GII.4 norovirus VP1 and their application in the study of a GII.6 norovirus-specific blockade epitope.
Huo Y; Ma J; Zheng L; Liu J; Yang Z; Wang C; Zhao Q
Arch Virol; 2022 Mar; 167(3):819-827. PubMed ID: 35112202
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine.
Chen W; Kang T; Yuan R; Shao C; Jing S
Biotechnol Lett; 2020 Jul; 42(7):1211-1218. PubMed ID: 32088791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
